Effects of alterations of glomerular fibrin deposition on renal inflammation in rats at different age stages

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 60, Issue 9, 2005, Pages 1099-1110

  Xi, Chunsheng ^a   Chen, Xiangmei ^a   Sun, Xuefeng ^a   Shi, Suozhu ^a   Feng, Zhe ^a   Wang, Jianzhong ^a   Hong, Quan ^a   Lu, Yang ^a   Lin, Shupeng ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; FIBRIN; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANEXAMIC ACID; UROKINASE;

AGE DISTRIBUTION; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DOWN REGULATION; FEMALE; FIBRIN DEPOSITION; GLOMERULUS; HYPOTHESIS; INFLAMMATION; INFLAMMATORY CELL; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE; UPREGULATION; VASCULAR ENDOTHELIUM;

EID: 25644458551     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/60.9.1099     Document Type: Article

References (28)

1. Ono T, Muso E, Suyama K, et al. Intraglomerular deposition of intact cross-linked fibrin in IgA nephropathy and Henoch Schonlein purpura nephritis. Nephron. 1996;74:522-528.
2. Ootaka T, Saito T, Soma J, Yusa A, Abe K. Mechanism of infiltration and activation of glomerular monocytes/macrophages in IgA nephropathy. Am J Nephrol. 1997;17:137-145.
3. McCutcheon J, Evans B, D'Cruz DP, Hughes GR, Davies DR. Fibrin deposition in SLE glomerulonephritis. Lupus. 1993;2:99-103.
4. Yamamoto K, Shimokawa T, Yi H, et al. Aging accelerates endotoxin-induced thrombosis increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging. Am J Pathol. 2002;161:1805-1814.
5. Hertig A, Rondeau E. Role of the coagulation/fibrinolysis system in fibrin-associated glomerular injury. J Am Soc Nephrol. 2004;15:844-853.
6. Middleton J, Patterson AM, Gardner L, Schmutz C, Ashton BA. Leukocyte extravasation: chemokine transport and presentation by the endothelium. Blood. 2002;100:3853-3860.
7. Chavakis T, Prissner KT, Santoso S. Leukocyte transendothelial migration: JAMs add new pieces to the puzzle. Thromb Haemost. 2003;89:13-17.
8. Levi M, Keller TT, van Gorp E, ten Cate H. Infection and inflammation and the coagulation system. Cardiovasc Res. 2003:60:26-39.
9. Kitching AR, Kong YZ, Huang XR, et al. Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis. J Am Soc Nephrol. 2003;14:1487-1495.
10. Harley SL, Powell JT. Fibrinogen up-regulates the expression of monocyte chemoattractant protein 1 in human saphenous vein endothelial cells. Biochem J. 1999;341:739-744.
11. Harley S, Struge J, Powell JT. Regulation by fibrinogen and its products of intercellular adhesion molecule-1 expression in human saphenous vein endothelial cells. Arterloscler Thromb Vasc Biol. 2000;20:652-658.
12. 3-RGDS interaction mediates fibrin-induced morphological changes of glomerular endothelial cells. Kidney Int. 1999;56:1413-1422.
13. Martinez J, Ferber A, Bach TL, Yaen CH. Interaction of fibrin with VE-cadherin. Ann N Y Acad Sci. 2001;936:386-405.
14. Drew AF, Tucker HL, Liu H, Witte DP, Degen JL, Tipping PG. Crescentic glomerulonephritis is diminished in fibrinogen-deficient mice. Am J Physiol Renal Physiol. 2001;281:1157-1163.
15. Cohen J. The immunopathogenesis of sepsis. Nature. 2002;420:885-891.
16. Terada Y, Eguchi Y, Nosaka S, Toba T, Nakamura T, Shimizu Y. Capillary endothelial thrombomodulin expression and fibrin deposition in rats with continuous and bolus lipopolysaccharide administration. Lab Invest. 2003;83:1165-1173.
17. Thomson NM, Moran J, Simpson IJ, Peters DK. Defibrination with ancrod in nephrotoxic nephritis in rabbits. Kidney Int. 1976;10:343-347.
18. Tipping PG, Erlich JH, Apostolopoulos J, Mackman N, Loskutoff D, Holdsworth SR. Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity and mRNA. Am J Pathol. 1995;147:1736-1748.
19. Naruse T, Tsuchida A, Ogawa S, Yano S, Maekawa T. Selective glomerular thrombosis in rats induced by combined injections of nephrotoxic antiserum and lipopolysaccharide. J Lab Clin Med. 1985;105:146-156.
20. Bianchi C, Araujo EG, Sato K, Sellke FW. Biochemical and structural evidence for pig myocardium adherens junction disruption by cardiopulmonary bypass. Circulation. 2001;104(Suppl I):I319-I324
21. Sutton TA, Mang HE, Campos SB, Sandoval RM, Yoder MC, Molitoris BA. Injury of the renal microvascular endothelium alters barrier function after ischemia. Am J Physiol Renal Physiol. 2003;285:F191-F198.
22. Wada T, Yokoyama H, Matsushima K, Kobayashi K. Chemokines in renal diseases. Int Immunopharmacol. 2001;1:637-645.
23. Altieri DC. Regulation of leukocyte-endothelium interaction by fibrinogen. Thromb Haemost. 1999;82:781-786.
24. Vincent PA, Xiao K, Buckley KM, Kowalczyk AP. VE-cadherin: adhesion at arm's length. Am J Physiol Cell Physiol. 2004;286: C987-C997.
25. Gotsch U, Borges E, Bosse R, et al. VE-cadherin antibody accelerates neutrophil recruitment in vivo. J Cell Sci. 1997;110:583-588.
26. Bobryshev YV, Cherian SM, Inder SJ, Lord RS. Neovascular expression of VE-cadherin in human atherosclerotic arteries and its relation to intimal inflammation. Cardiovasc Res. 1999;43:1003-1017.
27. Hunt BJ, Jurd KM. Endothelial cell activation. A central pathophysiological process. BMJ. 1998;316:1328-1329.
28. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol. 2004;15:1983-1992.